Strategic partnerships Wanda Health has actively pursued partnerships with clinical organizations such as the COPD Foundation and the American Heart Association, and recently partnered with Heart to strengthen access to clinical opinion leaders. This indicates a readiness to collaborate with influential health entities to expand reach and credibility.

Funding momentum The company has secured multiple funding rounds in 2024–2025, including UK and US investments totaling several million dollars, signaling strong investor confidence and a growth runway. These funds could support expanded sales efforts and new market entry.

Growth focus Recent leadership appointment of a new Chair and disclosed revenue in the $10–25 million range suggest ongoing scale-up activities. This creates opportunities to position Wanda Health as a proven, growing platform to health systems seeking virtual care modernization.

Technology leverage The tech stack emphasizes data-driven remote monitoring and AI-enabled capabilities (e.g., AI-enabled remote patient monitoring in development), which can be highlighted to enterprise buyers seeking predictive insights, early risk intervention, and scalable infrastructure.

Market positioning With a focus on complex cardiometabolic populations and enterprise-grade reporting, Wanda Health targets mid-market and health systems looking to reduce care costs and improve outcomes. This positions the company well for cross-sell opportunities into hospitals and health networks already investing in RPM and virtual care pathways.